For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Gilead Sciences (GILD – Free Report) been one of those stocks this year? By taking a look at the stock’s year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Gilead Sciences is a member of the Medical sector. This group includes 1011 individual stocks and currently holds a Zacks Sector Rank of #5. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Gilead Sciences is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for GILD’s full-year earnings has moved 4.2% higher within the past quarter. This means that analyst sentiment is stronger and the stock’s earnings outlook is improving.
Based on the most recent data, GILD has returned 16.8% so far this year. At the same time, Medical stocks have gained an average of 3.6%. As we can see, Gilead Sciences is performing better than its sector in the calendar year.
Another Medical stock, which has outperformed the sector so far this year, is AngioDynamics (ANGO – Free Report) . The stock has returned 11.1% year-to-date.
In AngioDynamics’ case, the consensus EPS estimate for the current year increased 9% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Gilead Sciences belongs to the Medical – Biomedical and Genetics industry, which includes 509 individual stocks and currently sits at #76 in the Zacks Industry Rank. This group has gained an average of 4.3% so far this year, so GILD is performing better in this area.
In contrast, AngioDynamics falls under the Medical – Instruments industry. Currently, this industry has 84 stocks and is ranked #76. Since the beginning of the year, the industry has moved -2.1%.
Investors interested in the Medical sector may want to keep a close eye on Gilead Sciences and AngioDynamics as they attempt to continue their solid performance.
Financial Market Newsflash
No financial news published today. Check back later.
